Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,253 | -1,678 | -7,676 | -5,738 | -4,015 |
| Depreciation Amortization | 108 | 55 | 220 | 165 | 110 |
| Accounts receivable | 90 | 68 | -92 | 53 | -113 |
| Other Working Capital | -422 | -328 | -369 | -1,035 | -616 |
| Other Operating Activity | 148 | 57 | 932 | 599 | 611 |
| Operating Cash Flow | $-4,329 | $-1,827 | $-6,986 | $-5,957 | $-4,022 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -9 | -9 | -9 |
| Investing Cash Flow | $0 | $0 | $-9 | $-9 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,426 | 1,030 | 5,216 | 5,216 | 5,216 |
| Other Financing Activity | -249 | -192 | -562 | -562 | -562 |
| Financing Cash Flow | $1,177 | $838 | $4,654 | $4,654 | $4,654 |
| Beginning Cash Position | 6,572 | 6,572 | 8,913 | 8,913 | 8,913 |
| End Cash Position | 3,419 | 5,583 | 6,572 | 7,601 | 9,535 |
| Net Cash Flow | $-3,152 | $-989 | $-2,341 | $-1,312 | $622 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,329 | -1,827 | -6,986 | -5,957 | -4,022 |
| Capital Expenditure | N/A | N/A | -9 | -9 | -9 |
| Free Cash Flow | -4,329 | -1,827 | -6,995 | -5,966 | -4,032 |